Treatment of Child Brain Cancer With New Gene Clue

Intriguing avenues to tackle lethal form of cancer have opened up with the newly found genetic mutations found in brain tumours in children, researchers said on Sunday.

Investigators found telltale mutations in a gene called ACVR1, which appears to play a role in a currently incurable form of childhood brain cancer called diffuse intrinsic pontine glioma, or DIPG.

Tumor Markers - For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results.

The mutations were found in 20 to 33 percent of DIPG biopsies in three different studies published in the journal Nature Genetics.

DIPG is the most aggressive brain tumour in children.

It develops in the brain stem, which is the seat of basic body functions that keep people alive, which means that it cannot be removed safely by surgery.

Psychological Intervention for Siblings of Paediatric Cancer Patients
Timely and individualized intervention can help improve the psycho-social health of the siblings of the paediatric cancer patients.

It is the first time that ACVR1 has been fingered in cancer.

A mutated form of ACVR1, though, has been identified previously in a rare disorder called "Stone Man syndrome," in which the body's muscles and tendons progressively turn to bone.

Progress, Challenges of Childhood Cancer Outlined in a New Report
The progress and challenges of childhood cancer are now outlined in a new report from the American Cancer Society

The work should also shed light on understanding some of the fundamental mechanisms of DIPG, including its progression from an early-stage condition, the Institut Gustave Roussy in Paris, which took part in one of the studies, said in a statement.

In addition, "specific inhibitor drugs" are being developed that may be of potential use against the faulty gene, it added.

About Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.

Source-AFP